Paysign Rides Prepaid Wave, Eyes $450B Market Growth by 2029
Ticker: PAYS · Form: 10-K · Filed: Mar 25, 2026 · CIK: 0001496443
| Field | Detail |
|---|---|
| Company | Paysign, Inc. (PAYS) |
| Form Type | 10-K |
| Filed Date | Mar 25, 2026 |
| Risk Level | medium |
| Pages | 14 |
| Reading Time | 17 min |
| Key Dollar Amounts | $0.001, $7.20, $450 billion, $350 billion |
| Sentiment | bullish |
Complexity: moderate
Sentiment: bullish
Topics: Prepaid Cards, Fintech, Payment Processing, Healthcare Payments, Corporate Incentives, Plasma Donation, Financial Technology
TL;DR
**PAYS is a buy, riding the massive tailwinds of the prepaid card market's explosive growth and specialized payment solutions.**
AI Summary
Paysign, Inc. (PAYS) reported a robust operational year ending December 31, 2025, with approximately 8.4 million cardholders across 670 card programs. The company, a vertically integrated provider of prepaid card products and processing services, derives revenue from cardholder fees, interchange, program management fees, transaction claims processing, breakage, and settlement income. Strategic expansion into life science technology solutions under the Apherion brand contributes licensing, hosting, and consulting fees. The open-loop prepaid card market is projected to grow at an 8% CAGR from 2025 to 2029, reaching $450 billion, with the cash access category alone expected to hit $350 billion by 2026. Paysign's focus on corporate incentives, healthcare reimbursement, and source plasma donor payments positions it to capitalize on this growth, offering solutions that reduce administrative costs and enhance customer loyalty for Fortune 500 companies and pharmaceutical manufacturers. The company's market value of non-affiliate common equity stood at $276,377,168 as of the last business day of its most recently completed second fiscal quarter, based on a $7.20 per share price.
Why It Matters
Paysign's strong position in the rapidly expanding prepaid card market, projected to reach $450 billion by 2029, signals significant growth potential for investors. The company's solutions, which streamline payments for corporate incentives, healthcare, and plasma donations, directly impact employees and customers by offering efficient, secure, and flexible payment options. This competitive edge, particularly in specialized markets like pharmaceutical patient affordability and source plasma donor payments, allows Paysign to differentiate itself from traditional payment processors and capture market share. Continued innovation in fintech and life science technology solutions could further solidify its market standing and attract new clients.
Risk Assessment
Risk Level: medium — The company operates in a highly competitive and regulated payment processing industry, as indicated by the 'Risk Factors' section (ITEM 1A). While the filing highlights significant market growth, Paysign's reliance on bank partners for card issuance and the evolving regulatory landscape for prepaid cards could introduce operational and compliance risks. The market value of $276,377,168 suggests a mid-cap company, which can be more susceptible to market fluctuations than larger, more diversified entities.
Analyst Insight
Investors should consider initiating a position in PAYS, given its strategic focus on high-growth prepaid card segments and its established client base including Fortune 500 companies. Monitor the company's ability to maintain its competitive differentiation in specialized markets and its adaptation to regulatory changes in the payment processing industry.
Financial Highlights
- debt To Equity
- N/A
- revenue
- N/A
- operating Margin
- N/A
- total Assets
- N/A
- total Debt
- N/A
- net Income
- N/A
- eps
- N/A
- gross Margin
- N/A
- cash Position
- N/A
- revenue Growth
- N/A
Revenue Breakdown
| Segment | Revenue | Growth |
|---|---|---|
| Cardholder Fees | N/A | N/A |
| Interchange | N/A | N/A |
| Program Management Fees | N/A | N/A |
| Transaction Claims Processing Fees | N/A | N/A |
| Breakage | N/A | N/A |
| Settlement Income | N/A | N/A |
| Apherion (Life Science Technology Solutions) | N/A | N/A |
Key Numbers
- $450 billion — projected total open-loop loads (by 2029, representing an 8% CAGR from 2025)
- $350 billion — projected cash access category growth (by 2026, growing at a 9% CAGR)
- 8.4 million — cardholders (as of December 31, 2025, across approximately 670 card programs)
- 670 — card programs (as of December 31, 2025)
- 8% — compound annual growth rate (CAGR) (for total open-loop loads from 2025 through 2029)
- 9% — compound annual growth rate (CAGR) (for the cash access category from 2025 through 2026)
- 27% — use of open-loop reloadable cards (in 2025, up from 20% in 2024)
- $276,377,168 — aggregate market value of common equity held by non-affiliates (as of the last business day of the most recently completed second fiscal quarter)
- $7.20 — market price per share (used to calculate aggregate market value of common equity)
- 55,185,394 — shares outstanding (as of March 19, 2026)
Key Players & Entities
- Paysign, Inc. (company) — registrant
- PAYS (company) — ticker symbol
- Nasdaq Stock Market LLC (regulator) — exchange where PAYS trades
- Apherion (company) — brand for life science technology solutions
- Javelin Advisory Services (company) — market research firm
- Visa (company) — payment network
- MasterCard (company) — payment network
- Discover (company) — payment network
- Securities and Exchange Commission (regulator) — filing oversight
- Sarbanes-Oxley Act (regulator) — governing financial reporting
Forward-Looking Statements
- Paysign, Inc. will continue to operate primarily in business services, consistent with its SIC code 7389. (Paysign, Inc.) — high confidence, target: 2027-03-25
- The company will file its next annual report (10-K) around March 2027 for the fiscal year ending December 31, 2026, following its historical filing pattern. (Paysign, Inc.) — high confidence, target: 2027-03-31
FAQ
What are Paysign's primary revenue streams?
Paysign generates revenue from cardholder fees, interchange, card program management fees, transaction claims processing fees, breakage, and settlement income. Additionally, its Apherion brand contributes licensing, hosting, and consulting fees from life science technology solutions.
How many cardholders and programs does Paysign manage?
As of December 31, 2025, Paysign managed approximately 8.4 million cardholders participating in approximately 670 card programs, demonstrating significant operational scale.
What is the projected growth for the open-loop prepaid card market, according to Javelin Advisory Services?
Javelin Advisory Services forecasts an 8% compound annual growth rate (CAGR) for total open-loop loads from 2025 through 2029, with projections reaching approximately $450 billion by 2029. The cash access category alone is expected to grow at a 9% CAGR, reaching $350 billion by 2026.
What types of prepaid cards does Paysign offer?
Paysign offers a diverse suite of prepaid card products, including corporate rewards, prepaid gift cards, general purpose reloadable debit cards, employee incentives, consumer rebates, donor compensation, clinical trials, healthcare reimbursement payments, and pharmaceutical payment assistance.
How does Paysign differentiate its medical claims-based affordability programs?
Paysign differentiates its medical claims-based affordability programs by offering accelerated adjudication and payments for medical claims compared to competitors. This is achieved through an internal proprietary platform designed to meet client needs and unique business rules, leading to stronger provider willingness to utilize their products.
What is Paysign's role in the source plasma donation industry?
Paysign provides a fully customized payment solution for source plasma donation centers, which predominantly use prepaid cards for donor compensation. This addresses the industry's shift from cash or check payments to more efficient digital solutions.
What is the significance of Paysign's 'breakage' revenue?
Breakage revenue for Paysign is recorded ratably over the estimated card life based on historical redemption patterns and market trends. This revenue stream is specifically tied to its open-loop gift card business, which commenced at the end of 2022, indicating a newer, growing segment of its financial operations.
What is Paysign's market value of common equity held by non-affiliates?
As of the last business day of its most recently completed second fiscal quarter, the aggregate market value of Paysign's voting and non-voting common equity held by non-affiliates was $276,377,168, based upon a market price of $7.20 per share.
What are the key benefits of Paysign's corporate incentive cards?
Key benefits of Paysign's corporate incentive cards include reduced operating and administrative costs, co-branding opportunities for clients, extensive customization options for card acceptance and reporting, and speed to market for delivering rewards and incentives to recipients.
What is Paysign's strategy for addressing patient affordability in the pharmaceutical market?
Paysign provides targeted products and services, including pharmacy-based voucher programs, medical claims-based affordability programs, and debit-based affordability programs, to address financial barriers for patients starting and remaining on brand name and biosimilar drug therapies. These solutions are designed to integrate with healthcare provider workflows and combat issues like copay accumulators.
Risk Factors
- Reliance on Third-Party Card Sponsors [medium — operational]: The company's prepaid card products are sponsored by issuing bank partners. A disruption in these relationships or the ability of these partners to maintain compliance could materially impact the company's ability to offer its products and services.
- Evolving Regulatory Landscape [medium — regulatory]: The prepaid card industry is subject to extensive and evolving regulations, including those related to consumer protection, anti-money laundering (AML), and Know Your Customer (KYC). Changes in these regulations could increase compliance costs and impact business operations.
- Cybersecurity Threats and Data Breaches [high — cybersecurity]: As a processor of sensitive financial and personal data, Paysign is a target for cyberattacks. A significant data breach could lead to reputational damage, regulatory penalties, and financial losses, impacting customer trust and business continuity.
- Competition in Prepaid and Fintech Markets [medium — market]: The prepaid card and fintech markets are highly competitive, with numerous players offering similar services. Intense competition could lead to pricing pressures and reduced market share, affecting revenue and profitability.
- Dependence on Key Customer Segments [medium — financial]: The company's revenue is derived from specific segments like corporate incentives, healthcare, and source plasma donors. A downturn or significant change in any of these key segments could disproportionately affect financial performance.
Industry Context
Paysign operates in the rapidly expanding open-loop prepaid card market, projected to reach $450 billion by 2029 with an 8% CAGR. The cash access category is a significant sub-segment, expected to hit $350 billion by 2026. The company competes by offering vertically integrated solutions that cater to specific needs in corporate incentives, healthcare, and donor payments, aiming to reduce costs and enhance loyalty for its clients.
Regulatory Implications
Paysign must navigate a complex and evolving regulatory environment governing prepaid financial products. Compliance with consumer protection laws, anti-money laundering (AML), and Know Your Customer (KYC) regulations is critical. Potential changes in these regulations could impact operational costs and product offerings.
What Investors Should Do
- Monitor Apherion segment growth
- Analyze customer concentration
- Evaluate competitive positioning
- Track cybersecurity investments and incidents
Key Dates
- 1995-08-24: Incorporation of Paysign, Inc. — Marks the legal establishment of the company.
- 2025-12-31: Year-end operational snapshot — Reported 8.4 million cardholders across 670 card programs, indicating significant scale.
- 2026-03-19: Shares outstanding reported — 55,185,394 shares outstanding provide a basis for per-share calculations.
Glossary
- Vertically Integrated
- A business model where a company controls multiple stages of its production or distribution process, from raw materials to final product delivery. (Paysign manages its prepaid card products and processing services end-to-end, offering greater control and potential efficiency.)
- Open-Loop Prepaid Card
- Prepaid cards that can be used at any merchant that accepts the card network (e.g., Visa, Mastercard), unlike closed-loop cards limited to a specific retailer. (This is a primary market for Paysign, with significant projected growth.)
- Interchange
- A fee paid by the merchant's bank to the cardholder's bank for each transaction processed. (A key revenue stream for Paysign from its card programs.)
- Breakage
- The unredeemed value on prepaid cards that is recognized as revenue by the issuer, typically after a dormancy period or card expiration, subject to escheatment laws. (A specific revenue source for Paysign's open-loop gift card business.)
- CAGR
- Compound Annual Growth Rate, a measure of the average annual growth rate of an investment over a specified period of time longer than one year. (Used to project future market growth in the open-loop prepaid card and cash access categories.)
- Apherion
- The brand name under which Paysign offers its life science technology solutions. (Represents a diversification of Paysign's business beyond traditional payment processing.)
Year-Over-Year Comparison
This analysis is based on the 2025 10-K filing. A direct comparison to the previous year's filing (2024) would require access to that document. However, the provided context indicates a positive operational year ending December 31, 2025, with significant cardholder and program growth, suggesting an upward trend in key business metrics compared to prior periods.
Filing Stats: 4,293 words · 17 min read · ~14 pages · Grade level 15.4 · Accepted 2026-03-25 08:05:00
Key Financial Figures
- $0.001 — nge on which registered Common Stock, $0.001 par value per share PAYS The Nasdaq S
- $7.20 — 76,377,168 based upon a market price of $7.20 per share. Indicate the number of shar
- $450 billion — loads projected to reach approximately $450 billion by 2029. The cash access category alone
- $350 billion — expected to grow at a 9% CAGR, reaching $350 billion by 2026. Consumers, both banked and un
Filing Documents
- paysign_i10k-123125.htm (10-K) — 1048KB
- paysign_ex2301.htm (EX-23.1) — 1KB
- paysign_ex3101.htm (EX-31.1) — 8KB
- paysign_ex3102.htm (EX-31.2) — 8KB
- paysign_ex3201.htm (EX-32.1) — 2KB
- paysign_ex3202.htm (EX-32.2) — 2KB
- 0001683168-26-002180.txt ( ) — 5987KB
- pays-20251231.xsd (EX-101.SCH) — 40KB
- pays-20251231_cal.xml (EX-101.CAL) — 56KB
- pays-20251231_def.xml (EX-101.DEF) — 165KB
- pays-20251231_lab.xml (EX-101.LAB) — 434KB
- pays-20251231_pre.xml (EX-101.PRE) — 352KB
- paysign_i10k-123125_htm.xml (XML) — 792KB
BUSINESS
BUSINESS 1 ITEM 1A.
RISK FACTORS
RISK FACTORS 11 ITEM 1B. UNRESOLVED STAFF COMMENTS 21 ITEM 1C. CYBERSECURITY 21 ITEM 2.
PROPERTIES
PROPERTIES 23 ITEM 3
LEGAL PROCEEDINGS
LEGAL PROCEEDINGS 24 ITEM 4. MINE SAFETY DISCLOSURE 25 PART II 26 ITEM 5. MARKET FOR REGISTRANT'S COMMON EQUITY, RELATED STOCKHOLDER MATTERS AND ISSUER PURCHASES OF EQUITY SECURITIES 26 ITEM 6. [RESERVED] 27 ITEM 7.
MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS
MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS 27 ITEM 7A.
QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK
QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK 36 ITEM 8.
FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA
FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA 36 ITEM 9. CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING AND FINANCIAL DISCLOSURE 37 ITEM 9A.
CONTROLS AND PROCEDURES
CONTROLS AND PROCEDURES 37 ITEM 9B. OTHER INFORMATION 38 ITEM 9C. DISCLOSURE REGARDING FOREIGN JURISDICTIONS THAT PREVENT INSPECTIONS 38 PART III 39 ITEM 10. DIRECTORS, EXECUTIVE OFFICERS AND CORPORATE GOVERNANCE 39 ITEM 11.
EXECUTIVE COMPENSATION
EXECUTIVE COMPENSATION 39 ITEM 12.
SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND RELATED STOCKHOLDER MATTERS
SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND RELATED STOCKHOLDER MATTERS 39 ITEM 13. CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS, AND DIRECTOR INDEPENDENCE 39 ITEM 14. PRINCIPAL ACCOUNTANT FEES AND SERVICES 39 PART IV 40 ITEM 15. EXHIBITS AND FINANCIAL STATEMENT SCHEDULES 40 ITEM 16 FORM 10-K SUMMARY 41
SIGNATURES
SIGNATURES 42 i Cautionary Note Regarding Forward Looking Statements This Annual Report on Form 10-K contains "forward-looking our business and our industry. Words such as "believe," "anticipate," "expect," "intend," "plan," "propose," "may," and other similar expressions identify forward-looking statements. In addition, any statements that refer to expectations, projections, estimates, forecasts, or other characterizations of future events or circumstances are forward-looking statements. These forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from those reflected in the forward-looking statements. You are cautioned not to place undue reliance on these forward-looking statements, which relate only to events as of the date on which the statements are made. We undertake no obligation to publicly revise these forward-looking statements to reflect events or circumstances that arise after the date hereof. You should refer to and carefully review the information in future documents we file with the Securities and Exchange Commission. ii PART I
BUSINESS
ITEM 1. BUSINESS. Overview Paysign, Inc. (the "Company," "Paysign," "we" or "our"), headquartered in Nevada, was incorporated on August 24, 1995, and trades under the symbol PAYS on The Nasdaq Stock Market LLC. We are a vertically integrated provider of prepaid card products and processing services for corporate, consumer and government entities. Our payment solutions are utilized by our corporate customers as a means to increase customer loyalty, increase patient adherence rates, reduce administration costs and streamline operations. We market our prepaid card solutions under our Paysign brand. As we are a payment processor and prepaid card program manager, we derive our revenue from all stages of the prepaid card lifecycle. In addition to our payment solutions, we also offer life science technology solutions targeting blood and plasma collection organizations. These software solutions are marketed under the Apherion brand, and we derive our revenue from licensing, hosting and consulting fees. We operate on a powerful, high-availability payment solutions platform with cutting-edge fintech capabilities that can be seamlessly integrated with our clients' systems. This distinctive positioning allows us to provide end-to-end technologies that securely manage transaction processing, cardholder enrollment, value loading, account management, data and analytics and customer service. Our architecture is known for its cross-platform compatibility, flexibility, and scalability – allowing our clients and partners to leverage these advantages for cost savings and revenue opportunities. Our suite of product offerings includes solutions for corporate rewards, prepaid gift cards, general purpose reloadable debit cards, employee incentives, consumer rebates, donor compensation, clinical trials, healthcare reimbursement payments and pharmaceutical payment assistance, demand deposit accounts accessible with a debit card and software solutions targeting blood and plasma collect